특허 및 논문

바이오솔빅스에 자료실을 확인해 보세요.
bt_bb_section_bottom_section_coverage_image

BIOSOLVIX ARCHIVE특허 및 논문

A comparison of human cord blood- and embryonic stem cell-derived endothelial progenitor cells in the treatment of chronic woun

작성자
관리자
작성일
2024-01-31 15:19
조회
187
Park SJ*, Moon SH*, Lee HJ, Lim JJ, Kim JM, Seo J, Yoo JW, Kim OJ, Kang SW, Chung HM. A comparison of human cord blood- and embryonic stem cell-derived endothelial progenitor cells in the treatment of chronic wounds. Biomaterials. 2013.34:995-1003.

Abstract

Endothelial progenitor cells (EPCs) promote new blood vessel formation and increase angiogenesis by secreting growth factors and cytokines in ischemic tissues. Therefore, EPCs have been highlighted as an alternative cell source for wound healing. EPCs can be isolated from various sources, including the bone marrow, cord blood, and adipose tissue. However, several recent studies have reported that isolating EPCs from these sources has limitations, such as the isolation of insufficient cell numbers and the difficulty of expanding these cells in culture. Thus, human embryonic stem cells (hESCs) have generated great interest as an alternative source of EPCs. Previously, we established an efficient preparation method to obtain EPCs from hESCs (hESC-EPCs). These hESC-EPCs secreted growth factors and cytokines, which are known to be important in angiogenesis and wound healing. In this study, we directly compared the capacity of hESC-EPCs and human cord blood-derived EPCs (hCB-EPCs) to benefit wound healing. The number of hESC-EPCs increased during culture and was always higher than the number of hCB-EPCs during the culture period. In addition, the levels of VEGF and Ang-1 secreted by hESC-EPCs were significantly higher than those produced by hCB-EPCs. After transplantation in a mouse dermal excisional wound model, all EPC-transplanted wounds exhibited better regeneration than in the control group. More importantly, we found that the wounds transplanted with hESC-EPCs showed significantly accelerated re-epithelialization. Thus, hESC-EPCs may be a promising cell source for the treatment of chronic wounds.


논문확인 (클릭시 이동)
전체 52
번호 제목 작성자 작성일 추천 조회
12
Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Endothelial Cells in Humanized Mouse Models Harboring a Human Immune
관리자 | 2024.01.31 | 추천 0 | 조회 213
관리자 2024.01.31 0 213
11
Development of a xeno- free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood.
관리자 | 2024.01.31 | 추천 0 | 조회 236
관리자 2024.01.31 0 236
10
The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction
관리자 | 2024.01.31 | 추천 0 | 조회 188
관리자 2024.01.31 0 188
9
Pertussis Toxin Enhances Colony Organization of Enzymatic-dissociated Single Human Embryonic Stem Cells.
관리자 | 2024.01.31 | 추천 0 | 조회 205
관리자 2024.01.31 0 205
8
Effective Method for the Isolation and Proliferation of Primary Lung Cancer Cells from Patient Lung Tissues.
관리자 | 2024.01.31 | 추천 0 | 조회 169
관리자 2024.01.31 0 169
7
Modification of a purification and expansion method for human embryonic stem cell-derived cardiomyocytes.
관리자 | 2024.01.31 | 추천 0 | 조회 185
관리자 2024.01.31 0 185
6
A comparison of human cord blood- and embryonic stem cell-derived endothelial progenitor cells in the treatment of chronic woun
관리자 | 2024.01.31 | 추천 0 | 조회 187
관리자 2024.01.31 0 187
5
Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo.
관리자 | 2024.01.31 | 추천 0 | 조회 232
관리자 2024.01.31 0 232
4
A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation.
관리자 | 2024.01.31 | 추천 0 | 조회 262
관리자 2024.01.31 0 262
3
Gene Expression Profiles in CHA3 and CHA4 Human Embryonic Stem Cells and Embryoid Bodies
관리자 | 2024.01.31 | 추천 0 | 조회 220
관리자 2024.01.31 0 220